Journal of Medical Economics, Volume 20, Issue 7 (2017)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 20, Issue 7 (2017)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Volume 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Diabetes

Article
Evaluation of the long-term cost-effectiveness of IDegLira versus liraglutide added to basal insulin for patients with type 2 diabetes failing to achieve glycemic control on basal insulin in the USA
B. Hunt, M. Mocarski, W. J. Valentine & J. Langer
Pages: 663-670
Published online: 15 Mar 2017
AbstractforEvaluation of the long-term cost-effectiveness of IDegLira versus liraglutide added to basal insulin for patients with type 2 diabetes failing to achieve glycemic control on basal insulin in the USA | Full Text | References | PDF (675.8 KB)
  • 1719 Views
  • 17 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
The cost-effectiveness of alectinib in anaplastic lymphoma kinase-positive (ALK+) advanced NSCLC previously treated with crizotinib
J. J. Carlson, W. Canestaro, A. Ravelo & W. Wong
Pages: 671-677
Published online: 23 Mar 2017
AbstractforThe cost-effectiveness of alectinib in anaplastic lymphoma kinase-positive (ALK+) advanced NSCLC previously treated with crizotinib | Full Text | References | PDF (913.2 KB)
  • 2129 Views
  • 20 CrossRef citations
  • 0Altmetric
Free Access

Gastroenterology

Article
Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France
Maureen Watt, Aurélien Dinh, Alban Le Monnier & Patrick Tilleul
Pages: 678-686
Published online: 16 Mar 2017
AbstractforCost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France | Full Text | References | PDF (935.9 KB)
  • 1632 Views
  • 18 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
Healthcare and economic burden of adverse events among patients with chronic myelogenous leukemia treated with BCR-ABL1 tyrosine kinase inhibitors
Jay Lin, Dinara Makenbaeva, Melissa Lingohr-Smith & Robyn Bilmes
Pages: 687-691
Published online: 12 Mar 2017
AbstractforHealthcare and economic burden of adverse events among patients with chronic myelogenous leukemia treated with BCR-ABL1 tyrosine kinase inhibitors | Full Text | References | PDF (512.9 KB)
  • 1052 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Hepatology

Article
Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States
Catherine Saint-Laurent Thibault, Divya Moorjaney, Michael L. Ganz, Bruce Sill, Shalini Hede, Yong Yuan & Boris Gorsh
Pages: 692-702
Published online: 20 Apr 2017
AbstractforCost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States | Full Text | References | PDF (1.4 MB)
  • 571 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Orthopaedics

Article
Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators
Jeroen P. Jansen, Devin Incerti, Alex Mutebi, Desi Peneva, Joanna P. MacEwan, Bradley Stolshek, Primal Kaur, Mahdi Gharaibeh & Vibeke Strand
Pages: 703-714
Published online: 05 Apr 2017
AbstractforCost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators | Full Text | References | PDF (1.2 MB) | Supplemental
  • 2983 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access

Nephrology

Article
Cost-effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers as first-line treatment in autosomal dominant polycystic kidney disease
L. A. Clark, S. Whitmire, S. Patton, C. Clark, C. M. Blanchette & R. Howden
Pages: 715-722
Published online: 13 Apr 2017
AbstractforCost-effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers as first-line treatment in autosomal dominant polycystic kidney disease | Full Text | References | PDF (1.2 MB)
  • 995 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Cardiovascular

Article
Economic evaluation of ezetimibe treatment in combination with statin therapy in the United States
Glenn M. Davies, Ami Vyas & Carl A. Baxter
Pages: 723-731
Published online: 15 May 2017
AbstractforEconomic evaluation of ezetimibe treatment in combination with statin therapy in the United States | Full Text | References | PDF (978.2 KB) | Supplemental
  • 1264 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access
Article
Global health resource utilization associated with pacemaker complications
Catherine Waweru, Anna Steenrod, Claudia Wolff, Simon Eggington, David Jay Wright & Kathleen W. Wyrwich
Pages: 732-739
Published online: 28 Apr 2017
AbstractforGlobal health resource utilization associated with pacemaker complications | Full Text | References | PDF (790.9 KB) | Supplemental
  • 651 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Pharmacotherapy

Article
Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study
James Kenworthy, Yunni Yi, Antony Wright, Jim Brown, Ana Maria Madrigal & William C. N. Dunlop
Pages: 740-748
Published online: 25 May 2017
AbstractforUse of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study | Full Text | References | PDF (1.1 MB) | Supplemental
  • 4361 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access

Cardiovascular

Article Commentary
Why published studies of the cost-effectiveness of PCSK-9 inhibitors yielded such markedly different results
Peter P. Toth, Warren Stevens & Jacquelyn W. Chou
Pages: 749-751
Published online: 17 May 2017
First Page PreviewforWhy published studies of the cost-effectiveness of PCSK-9 inhibitors yielded such markedly different results | Full Text | References | PDF (344.7 KB)
  • 1263 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Hospital Practice

Article
The differential rates in cost-related non-adherence to medical care by gender in the US adult population
James X. Zhang, James M. Crowe & David O. Meltzer
Pages: 752-759
Published online: 19 May 2017
AbstractforThe differential rates in cost-related non-adherence to medical care by gender in the US adult population | Full Text | References | PDF (849.6 KB)
  • 730 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access

Ophthalmology

Article
Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma
John P. Berdahl, Anup K. Khatana, L. Jay Katz, Leon Herndon, Andrew J. Layton, Tiffany M. Yu, Matthew J. Bauer & Louis B. Cantor
Pages: 760-766
Published online: 13 Jun 2017
AbstractforCost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma | Full Text | References | PDF (1.2 MB)
  • 3747 Views
  • 25 CrossRef citations
  • 0Altmetric
Free Access

Cardiovascular

Article
A systematic literature review of methods of incorporating mortality in cost-effectiveness analyses of lipid-lowering therapies
Jesse D. Ortendahl, Amanda L. Harmon, Tanya G. K. Bentley & Michael S. Broder
Pages: 767-775
Published online: 09 Jun 2017
AbstractforA systematic literature review of methods of incorporating mortality in cost-effectiveness analyses of lipid-lowering therapies | Full Text | References | PDF (856.7 KB) | Supplemental
  • 895 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Explore articles